NissensonA.R., PrichardS.S., ChengI.K.P.Non medical factors that impact on ESRD modality selection.Kidney Int1993; 43: S120–S127.
2.
MaiorcaR., VoneshE., CancariniG.C.A six year comparison of patient and technique survivals in CAPD and HD.Kidney Int1988; 34: 518–24.
3.
MaiorcaR., CancariniG.C.Outcome of peritoneal dialysis: comparative studies. In: GokalR., NolphK.D. eds. The textbook of peritoneal dialysis.Dordrecht: Kluwer Academic Publishers, 1994: 699–734.
4.
BloembergenW.E., PortF.K., MangerE.A., WolfeR.A.Comparison of mortality in prevalent HD and PD treated dialysis patients.J Am Soc Nephrol1993; 4: 335.
5.
ChurchillD.N., ThorpeK., TaylorD.W., KeshaviahP.K.Adequacy of peritoneal dialysis.J Am Soc Nephrol1994; 5: 439.
6.
LowrieE.G., LewN.L., HuangW.H.Evaluation of death risk predictors among peritoneal dialysis patients.Am J Kidney Dis1995 (in press).
7.
LupoA., TarchiniR., CancariniG.C.Long term outcome in CAPD: a 10-year survey by the Italian Cooperative PD Study Group.Am J Kidney Dis1994; 24: 826–37.
8.
GentilM.A., CarriagoA., PayonM.Comparison of survival in CAPD and hospital haemodialysis: a multicentre study.Nephrol Dial Transplant1991; 6: 444–51.
9.
FallerB., LamierN.Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years.Nephrol Dial Transplant1994; 9: 280–6.
10.
De VecchiA., ScalamognaA., MaccaroM.Can CAPD work for more than 10 years?Nephrol Dial Transplant1995; 10: 1038.
11.
DobbieJ.W.Ultrastructure and pathology of the peritoneum in peritoneal dialysis. In: GokalR., NolphK.D. eds. The textbook of peritoneal dialysis.Dordrecht: Kluwer Academic Publishers, 1994: 17–44.
12.
DobbieJ.W.Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis.Perit Dial Int1992; 12: 14–27.
13.
ColesG., LewisS.L., WilliamsJ.D.Host defence and effects of solutions on peritoneal cells. In: GokalR., NolphK.D. eds. The textbook of peritoneal dialysis.Dordrecht: Kluwer Academic Publishers, 1994: 503–28.
14.
AteshkadiA., JohnsonC.A., FoundsH.W., ZimmermanS.W.Serum advanced glycosylation end-products in patients on HD and CAPD.Perit Dial Int1995; 15: 129–33.
15.
LambE., Cat tellW.R., DawnayA.B.In vitro formation of advanced glycation end products in peritoneal dialysis fluid.Kidney Int1995; 46: 1768–74.
16.
MistryC.D., GokalR., PeersE.Midas Study Group. A randomised multi centre clinical trial comparing isosmolar dextrin 20 with hyperosmolar glucose solutions in CAPD: a six month study.Kidney Int1994; 46: 496–503.
17.
KoppleJ.D., BernardD., MessanaJ.Treatment of malnourished CAPD patients with an amino acid based dialysate.Kidney Int1995; 47: 1148–57.
18.
FerianiM., BiasioliS., BarbaciniS.Acid base correction with bicarbonate solutions in CAPD patients. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G. eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1989; 5: 191–4.
19.
YatzidesH.A new stable bicarbonate dialysis solution for peritoneal dialysis; preliminary report.Perit Dial Int1991; 11: 224–7.
20.
MistryC.D., GokalR.New osmotic agents for peritoneal dialysis: where we are and where we're going.Semin Dial1991; 4: 9–12.
21.
RippeB., SimonsenO., StelinG.Clinical implications of a three-pore model of peritoneal transport. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., OreopoulosD.G. eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1991; 7: 3–9.
22.
AgreP., PrestonG.M., SmithB.L.Aquaporin CHIP: the archetypal molecular water channel.Am J Physiol1993; 265(Renal Fluid Electrolyte Physio 34): F463–F476.
OtaK., MinishumaM., WatanabeM., NaganumenS.Functional deterioration of the peritoneum; does it occur in the absence of peritonitis?Nephrol Dial Transplant1987; 2: 30–3.
25.
KeshaviahP.Adequacy of peritoneal dialysis. In: GokalR., NolphK.D. eds. The textbook of peritoneal dialysis.Dordrecht: Kluwer Academic Publishers, 1994: 419–42.
JensonR.A., NolphK.D., MoonH.Weight limitations for adequate therapy using commonly performed CAPD and NIPD regimes.Semin Dial1994; 7: 61–4.
28.
YoungG.A., KoppleJ., LindholmB.Nutritional assessment of patient on CAPD; an international study.AmJKidneyDis1991; 17: 462–71.
29.
TeehanB.P., SchaferC., BrownJ.Urea kinetic analysis and outcome on CAPD: a five year longitudinal study. In: KhannaR., NolphK.D., ProwantB.F., TwardowskiZ.J., Oreopoulos00 eds. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Bulletin Inc., 1991; 6: 181–5.
30.
HartyJ., GokalR.Nutritional status in peritoneal dialysis.J Renal Nutrition1995; 5: 2–10.
31.
FerianiM., La GrecaG., KrigerF.L., WinchesterJ.F.CAPD systems and solutions. In: GokalR., NolphK.D. eds. The textbook of peritoneal dialysis.Dordrecht: Kluwer Academic Publishers, 1994: 233–70.
32.
BernadiniJ., PirainoB.Analysis often year trends in infections in adults on CAPD.Clin Nephrol1991; 36: 29–34.
33.
GokalR., AshS., Baird HelfrichG.Peritoneal catheters and exit site practices: towards optimal peritoneal access.Perit Dial Int1993; 13: 29–40.
34.
TwardowskiZ.J., ProwantB.F., NicholW.K.Six years experience with a Swan neck catheter.Perit Dial Int1992; 12: 384–9.
35.
TwardowskiZ.J., DobbieJ., MooreH.L.Morphology of peritoneal dialysis catheter tunnels. Macroscopy and light microscopy.Perit Dial Int1991; 11: 237–51.
36.
GokalR.Quality of life in patients undergoing renal replacement therapy.Kidney Int1993; 40(Suppl 38): S23–S27.
37.
NissensonA.R.Measuring, managing, and improving quality in the end stage renal disease treatment setting: peritoneal dialysis.Am J Kidney Dis1994; 24: 368–75.
38.
MaiorcaR.Personal communication. Symposium on long term viability of PD. EDTA, 1995.
